He and colleagues[37] reported that in non‐alcoholic steatohepatitis (NASH)‐induced Hepatocellular carcinoma (HCC) models, ATF4 deficiency increased susceptibility to ferroptosis via decreasing XCT expression, leading to accelerated development of HCC. Here, SLC7A11 is linked to metabolic dysfunction-associated steatohepatitis.